Intuitive Surgical Inc (ISRG) carries a ŷRobot AI score of 71 out of 100. The model's fair value estimate is $433.88, 1.4% above the last close of $427.86. The chart signal reads SS-Sell.
| Metric | ISRG |
|---|---|
| AI score | 71 / 100 |
| Chart signal | SS-Sell |
| Fair value estimate | $433.88 |
| Upside to fair value | 1.4% |
| Previous close | $427.86 |
| P/E | 47.17 |
| Price / sales | 13.03 |
| Market cap | $149.10B |
| EPS | 8.62 |
| Revenue growth | 16.1% |
| 1-year price change | 9.4% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Incorporated, Merck & Company Inc, Novartis AG ADR.
As of Oct 15, 2026, ŷRobot's fair-value model estimates Intuitive Surgical Inc (ISRG) at $433.88 against a last close of $427.86, implying 1.4% upside to the model's estimate.
The chart-signal model classifies ISRG as Bearish as of Oct 15, 2026, with a signal score of -0.19 on a -1 to 1 scale.
ISRG scores 71 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 15, 2026.
ISRG trades at 47.2 times earnings and 13.0 times sales as of Oct 15, 2026.
ŷRobot's seasonal forecast curve for ISRG reads +8.6% at 30 days, +13.1% at 90 days, and +9.4% at one year as of Oct 15, 2026. Seasonal tendencies are historical patterns, not predictions.
Intuitive Surgical Inc's revenue growth is +16.1% and free-cash-flow growth is +4.6% on the latest reported figures.
ISRG chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.